{
    "clinical_study": {
        "@rank": "43631", 
        "arm_group": [
            {
                "arm_group_label": "Arm I (early intervention)", 
                "arm_group_type": "Experimental", 
                "description": "Beginning within 2 weeks of starting chemoradiation, patients undergo an individualized rehabilitation program comprising aerobic exercise and strength training, including treadmill walking, stationary bicycle, NU-Step, upper body resistance training and breathing retraining, 3 times per week for 8 weeks (36 sessions)."
            }, 
            {
                "arm_group_label": "Arm II (late intervention)", 
                "arm_group_type": "Experimental", 
                "description": "Beginning 1 month after completion of chemoradiation, patients undergo an individualized exercise rehabilitation program as in Arm I."
            }
        ], 
        "brief_summary": {
            "textblock": "This randomized clinical trial studies pulmonary rehabilitation in improving lung function\n      in patients with locally advanced non-small cell lung cancer undergoing chemoradiation.\n      Individualized exercise rehabilitation programs may reduce breathing problems and improve\n      quality of life in patients with non-small cell lung cancer. It is not yet known whether\n      pulmonary rehabilitation is more effective when started during or after cancer treatment."
        }, 
        "brief_title": "Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation", 
        "condition": [
            "Cachexia", 
            "Fatigue", 
            "Pulmonary Complications", 
            "Radiation Toxicity", 
            "Recurrent Non-small Cell Lung Cancer", 
            "Stage IIIA Non-small Cell Lung Cancer", 
            "Stage IIIB Non-small Cell Lung Cancer", 
            "Stage IV Non-small Cell Lung Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cachexia", 
                "Carcinoma, Non-Small-Cell Lung", 
                "Fatigue", 
                "Lung Neoplasms", 
                "Radiation Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. To determine feasibility of pulmonary rehabilitation (PR) in patients with locally\n      advanced unresectable non-small cell lung cancer (NSCLC) undergoing definite chemotherapy\n      and radiation therapy.\n\n      II. To measure exercise capacity and respiratory symptoms in lung cancer patients receiving\n      chemotherapy and radiation before and after pulmonary rehabilitation.\n\n      III. To compare if there are any differences in symptom relief, exercise capacity, and\n      cancer treatment tolerability between performing pulmonary rehabilitation during\n      chemo-radiation versus after completion of lung cancer treatment.\n\n      OUTLINE: Patients are randomized to 1 of 2 arms.\n\n      ARM I: Beginning within 2 weeks of starting chemoradiation, patients undergo an\n      individualized rehabilitation program comprising aerobic exercise and strength training,\n      including treadmill walking, stationary bicycle, NU-Step, upper body resistance training and\n      breathing retraining, 3 times per week for 8 weeks (36 sessions).\n\n      ARM II: Beginning 1 month after completion of chemoradiation, patients undergo an\n      individualized exercise rehabilitation program as in Arm I."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who have been diagnosed with locally advanced unresectable NSCLC undergoing\n             definite chemo-radiation with curative intent\n\n          -  Patients must be able to sign informed consent\n\n          -  Patients who qualify for pulmonary rehabilitation as part of the standard of care and\n             are covered by medical insurance\n\n          -  Patients must be able to ambulate a minimum of 100 feet prior to enrollment in\n             pulmonary rehab\n\n          -  Patients must be willing and able to travel to the pulmonary rehabilitation site at\n             the Morehouse Medical Plaza\n\n        Exclusion Criteria:\n\n          -  Tumor resection candidates\n\n          -  If survival is deemed less than 6 months for any medical condition\n\n          -  If they have angina or unstable coronary disease\n\n          -  Congestive heart failure refractory to medical management\n\n          -  Malignancy with bone instability\n\n          -  Inmates"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02017925", 
            "org_study_id": "OSU-13044", 
            "secondary_id": "NCI-2013-02215"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Arm I (early intervention)", 
                    "Arm II (late intervention)"
                ], 
                "description": "Undergo pulmonary rehabilitation", 
                "intervention_name": "exercise intervention", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Arm I (early intervention)", 
                    "Arm II (late intervention)"
                ], 
                "description": "Undergo pulmonary rehabilitation", 
                "intervention_name": "pulmonary complications management/prevention", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "Arm I (early intervention)", 
                    "Arm II (late intervention)"
                ], 
                "description": "Ancillary studies", 
                "intervention_name": "quality-of-life assessment", 
                "intervention_type": "Procedure", 
                "other_name": "quality of life assessment"
            }, 
            {
                "arm_group_label": [
                    "Arm I (early intervention)", 
                    "Arm II (late intervention)"
                ], 
                "description": "Ancillary studies", 
                "intervention_name": "questionnaire administration", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pulmonary Rehabilitation", 
            "Non-Small Cell Lung Cancer", 
            "NSCLC"
        ], 
        "lastchanged_date": "March 28, 2014", 
        "link": {
            "description": "The Jamesline", 
            "url": "http://cancer.osu.edu"
        }, 
        "location": {
            "contact": {
                "email": "Michael.ezzie@osumc.edu", 
                "last_name": "Michael Ezzie, MD", 
                "phone": "614-293-4925"
            }, 
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43210"
                }, 
                "name": "Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Michael Ezzie, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Hiram Rivas-Perez, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Philip Diaz, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Miguel Villalona, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Vincent Esguerra, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pulmonary Rehabilitation in Locally Advanced Non-Small Cell Lung Cancer", 
        "overall_contact": {
            "email": "michael.ezzie@osumc.edu", 
            "last_name": "Micahel Ezzie, MD", 
            "phone": "614-293-4925"
        }, 
        "overall_official": {
            "affiliation": "Ohio State University Comprehensive Cancer Center", 
            "last_name": "Michael Ezzie", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Either a two-sided t-test or a Wilcoxon-rank sum test will be used to test the difference in the improvement of the 6 minute walk depending on the distribution. This test will be used to compare the difference in improvement between PR during chemo-radiation of NSCLC patients and PR 8 weeks post chemo-radiation. Linear regression will be used to estimate which clinical characteristics and patient demographics are associated with improvement in 6 minute walk. The study population will be described using means and standard deviations or medians and the interquartile range.", 
            "measure": "Percent improvement in the 6 minute walk from prior to post PR", 
            "safety_issue": "No", 
            "time_frame": "Baseline to up to 8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02017925"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ohio State University Comprehensive Cancer Center", 
            "investigator_full_name": "Michael Ezzie", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Percent improvement in the St. George Respiratory Questionnaire (SGRQ) score", 
                "safety_issue": "No", 
                "time_frame": "Baseline to up to 8 weeks"
            }, 
            {
                "description": "Either Pearson's chi-square of Fisher's exact methods will be used to test if the feasibility differs across groups. Logistic regression will be used to estimate which clinical characteristics and patient demographics are associated with feasibility.", 
                "measure": "Feasibility of the program, based on number of patients attending the sessions throughout the 8 weeks", 
                "safety_issue": "No", 
                "time_frame": "Up to 8 weeks"
            }
        ], 
        "source": "Ohio State University Comprehensive Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ohio State University Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}